SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Market Gems:Stocks w/Strong Earnings and High Tech. Rank

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jenna who wrote (97009)5/10/2000 3:26:00 PM
From: Jenna  Read Replies (2) of 120523
 
KING... very particular to this one gang.. I'll try to be objective.. but I love it. Do you own DD (I love it) whoops! Not a daytrade, not really. Going to NYSE.. so its not a 'pump & dump' either ;-)

King Pharmaceuticals to List on the New York Stock Exchange
BRISTOL, Tenn., May 9 /PRNewswire/ -- King Pharmaceuticals, Inc. (Nasdaq: KING - news) announced today that it has filed a listing application with the New York Stock Exchange (``NYSE''). The NYSE previously informed King that it meets the eligibility requirements for listing King's common stock on the NYSE. King expects its shares to begin trading under the symbol ``KG'' on or about May 23, 2000, pending final approval from the NYSE. Until that time, the Company will continue trading on Nasdaq under the symbol ``KING.'' King has traded on the Nasdaq National Market since June 1998, when the Company completed its initial public offering.

John M. Gregory, Chairman and Chief Executive Officer of King, stated, ``We look forward to King's listing on the New York Stock Exchange which we believe will benefit our shareholders by providing increased visibility to a larger base of potential investors and greater stability through the NYSE's highly structured trading environment. King's move to the NYSE will represent another milestone in our Company's history arising from our continued successful execution of the Company's growth strategies.''
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext